Intellia Therapeutics Inc buy BenchmarkLong70
Start price
29.10.24
/
50%
€15.30
Target price
29.11.24
-
Performance (%)
-2.62%
End price
30.11.24
€14.90
Summary
This prediction ended on 30.11.24 with a price of €14.90. With a performance of -2.62%, the BUY prediction for Intellia Therapeutics Inc by BenchmarkLong70 closed slightly in the red. BenchmarkLong70 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -6.653% | -6.653% | -40.136% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by BenchmarkLong70 for this prediction
In the thread Trading Intellia Therapeutics Inc
Die von BenchmarkLong70 gewählte maximale Laufzeit wurde überschritten